Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
|
12.02.01 |
Drugs used in nasal allergy |
|
|
Azelastine and fluticasone (Dymista) (nasal spray)
|
Third Choice
|
Third line therapy for allergic rhinitis where response to treatment with other therapies, including combination of oral antihistamines and intranasal corticosteroids, was inadequate or not tolerated
|
Budesonide (Rhinocort Aqua®)

|
Non Formulary
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
Status |
Description |

|
Suitable for prescribing by all in both primary and secondary care. |

|
Specialist recommended but suitable for continuation in primary care. |

|
Specialist initiated but suitable for continuation in primary care. |

|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |

|
Suitable for prescribing in specialist settings (secondary care) only. |

|
Secondary care medicines to be used under specialised commissioning arrangements only. |

|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |

|
Not recommended for use. |
|
|